Leptin and interleukin-6 in end-stage renal disease

Pakistan Journal of Medical Sciences

Volumn 24, Issue 5, 2008, Pages 694-697

  Dashti, Nasrin ^a   Einollahi, Nahid ^a   Nabatchian, Fariba ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ESRD patients; Interleukin 6; Leptin

Indexed keywords

INTERLEUKIN 6; LEPTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; INTERLEUKIN 6 BLOOD LEVEL; IRAN; KIDNEY CLEARANCE; KIDNEY FAILURE; LEPTIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

EID: 55849095492     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Campfield LA, Smith F, Guisez Y. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-9.
2. Halaas JL, Gajiwala KS, Maffei M. Weight-reducing effects of the plasma protein encoded by obese gene. Science 1995;269:543-6.
3. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T. Effects of the obese gene products on body weight regulation in ob/ob mice. Science 1995;269:540-3.
4. Masuzaki H, Ogawa Y, Isse N, Satoh N. Human obese gene expression: adipocyte-specific expression and regional differences in adipose tissue. Diabetes 1995;44:855-8.
5. Zhang Y, Proenca R, Maffei M, Barone M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
6. Merabet E, Dagogo-Jack S, Coyne D, Klein S. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrin Metabolism 1997;82:847-50.
7. Sharma K, Considine R, Micheal B, Dunn S. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney International 1997;51:1980-5.
8. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;11:1303-9.
9. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, Laquier F, Manetta J. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271:10:5301-4.
10. Libbie P, Briley, Lynda A. Leptin and Renal disease. Seminars in Dialysis 2006;19(1):54-9.
11. Wiesholzer M, Harm F, Hauser AC, Pribasnig A, Balcke P. Inappropriately high plasma leptin levels in obese haemodialysis patients can be reduced by high flux haemodialysis and haemofiltration. Clin Sci (Colch) 1998;94:431-5.
12. Howard JK, Lord GM, Clatterbuck EJ, Ghatei MA, Pusey CD. Plasma immunoreactive leptin concentration in end-stage. Clin Sci (Colch) 1997;93:119-26.
13. Widjaja A, Kiestein JT, Horn R, Muhlen A, Kliem V, Brabant G. Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease. Nephrol Dial Transplant 2000;15:846-50.
14. Coyne DW, Dagogo-Jack S, Klein S, Merabet E, Audrian J, Landt M. High-Flux dialysis lowers plasma leptin concentration in chronic dialysis patients. Am J Kidney Dis 1998;32:1031-5.
15. Landt M, Parvin CA, Dagogo-Jack S, Bryant B, Coyne DW. Leptin elimination in hyperleptinaemic peritoneal dialysis patients. Nephrol Dial Transplant 1999;14:732-7.
16. Tsujimoto Y, Shoji T, Tabata T. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1999;34:832-8.
17. Pereira BJ, Shapiro L, King AJ, Falagas ME. Plasma levels of IL-1 beta TNF-alfa and their specific inhibitors in undialyzed chronic renal failure CAPD and hemodialysis patients. Kidney Int 1994;45:890-6.
18. Libetta C, De Nicola L, Rampino T, Desimone W, Memoli B. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation. Kidney Int 1996;49:506-11.
19. Nordfors L, Lonnquist F, Heimburger O, Danielsson A, Schalling M. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 1998;54:1267-75.
20. Fouque D, Sereni L, Gharib C, Laville M, Tetta C. Leptin is a positive acute phase protein in hemodialysis. J Am Soc Nephrol 2001;12:355 A.
21. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152-7.
22. Faggioni R, Jones-Garson J, Reed DA, Dinarello CA. Leptin deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity. Role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci USA 1998;97:2367-72.
23. Pecoits-Filho R, Nord Fors L, Heimburger O. Soluble leptin receptors and serum leptin in end-stage renal disease: Relationship with inflammation and body composition. Eur J Clin Invest 2002;32(11):811-17.
24. Janik JE, Curti BD, Considine RV, Rager HC, Powers GC. Interleukin 1 alpha increases serum leptin concentrations in human. J Clin Endocrine Metab 1997;82:3084-6.
25. Zumbach MS, Bochme MW, Wahl P, Stremmel W, Ziegler R. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrin Metab 1997;82:4080-2.
26. Tripepi G, Mallamaci F, Zoccal C. Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modelling. J Am Soc Nephrol 2005;16:83-8.
27. Stenvinkel P, Alvestrand A. Inflammation in End-Stage Renal Disease: Sources, Consequences, and Therapy. Seminars in Dialysis 2002;15(15):329-35.